abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Total Costs & Expenses
-$69.85M
TTM · Period ending: · USD
HQL Total Costs & Expenses
Latest reported-$69.85Mperiod ending
Latest reported-$69.85Mperiod ending
HQL Total Costs & Expenses ($1.89M → -$69.85M)
Annual Total Costs & Expenses
High-resolution chart · PNG
HQL total costs & expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 791,573 | |
| 1,388,771 | |
| 17,031,127 | |
| 136,467,914 | |
| -19,514,427 | |
| -83,992,529 | |
| 5,319,624 | |
| 5,592,934 | |
| 5,560,940 | |
| 1,342,612 | |
| 39,176,719 | |
| 88,390,469 | |
| 84,128,540 | |
| 75,485,597 | |
| 4,370,000 | |
| 3,780,000 | |
| 3,610,000 | |
| 4,580,000 | |
| 4,590,000 | |
| 3,640,000 | |
| 3,470,000 | |
| 3,390,000 | |
| 2,950,000 | |
| 3,450,000 | |
| 3,710,000 | |
| 1,880,000 | |
| 1,860,000 | |
| 1,890,000 |